Coherus Oncology, Inc. (CHRS)

NASDAQ: CHRS · Real-Time Price · USD

0.8778

-0.0624 (-6.64%)

At close: Aug 1, 2025, 4:00 PM

0.8900

+0.0122 (1.39%)

After-hours: Aug 1, 2025, 7:58 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Human Pharmaceutical Products	257.24M	Log In	Log In	Log In	Log In	Upgrade
Human Pharmaceutical Products Growth	21.89%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	257.24M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	21.89%	Log In	Log In	Log In	Log In	Upgrade